Author: Damerow, T.
Paper Title Page
MOPPT002 Status of the HZB Cyclotron 31
  • A. Denker, J. Bundesmann, T. Damerow, T. Fanselow, W. Hahn, G. Heidenreich, D. Hildebrand, U. Hiller, U. Muller, C. Rethfeldt, J. Röhrich
    HZB, Berlin, Germany
  • D. Cordini, J. Heufelder, R. Stark, A. Weber
    Charite, Berlin, Germany
  For 15 years, eye tumours are treated in collaboration with the Charité - Universitätsmedizin Berlin. In 2012 we celebrated the 2000th patient. Our cyclotron is again served by 2 different injectors: a 6 MV Van-de-Graaff and a 2 MV tandetron. The tandetron was optimized especially for the requirements of therapy. Its advantages are easier handling, lower service requirements and a shorter injection beam line. Development of the source resulted in safe operation of more than 600 h and extremely stable beam current. The tandetron is in operation for therapy since 2011. The Van-de-Graaff was considered to be a temporary backup. New requests for beams with a very specific time structure occurred, which can be provided only with the Van-de-Graaff-cyclotron beam line. Pulse structures of high variability; from single pulses of 1 ns at a max. repetition rate of 75 kHz to pulse packets with a length up to 100 μs were tested. The latter was used for the production of pulsed neutron radiation for comprehensive testing of dosimeters. Although major breakdowns have a huge impact on the up-time due to the small number of beam time hours, breakdowns over the past years amounted to less than 5%.  
TH2PB04 A Multi-Leaf Faraday Cup Especially for Proton Therapy of Ocular Tumors 458
  • C.S.G. Kunert, J. Bundesmann, T. Damerow, A. Denker
    HZB, Berlin, Germany
  • A. Weber
    Charite, Berlin, Germany
  The Helmholtz-Zentrum Berlin (HZB) provides together with the University Hospital Charité in Berlin a treatment of eye tumors with a proton beam. The 68 MeV proton beam is delivered by an isochronous cyclotron as main accelerator. In tumor irradiation treatment the positioning of the radiation field is very important. In eye tumor treatment it is even more important, due to the small and sensitive structures in the eye. Hence, due to the well defined Bragg peak, a proton beam is a good choice to achieve rather small fields of dose delivery. Again, due to the small structures in the eye, one needs to know the proton beam energy and the proton beam range with a high accuracy. One possible solution for a quick and high precision measurement of the range of such proton beams is a Multi-Leaf Faraday Cup (MLFC). This work has the task to develop such a MLFC concerning the special requirements of the eye tumor therapy. In this presentation an overview of the progress of this work will be given, regarding the MLFC principles and issues such as the first technical realization.  
slides icon Slides TH2PB04 [5.358 MB]